Apotheek Bellens SRL

Apotheek Bellens reported total assets of 195,155 € at the end of the 2024 financial year (annual accounts filed with the NBB on 02 Sep 2025).

Company number (CBE) 0426.644.008 · VAT BE0426644008
9160 Lokeren
active in Retail sale of pharmaceutical products (NACE 47730)
operating since 29 Dec 1984 (≈ 42 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Apotheek Bellens shows with a free account.

See the score
Profile
SRL since 1984
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2024

Net result−2,680 €
Equity17,176 €
Cash11,010 €
EBITDA58,889 €
Total assets195,155 €
The line marks its sector median: 44.2% (2068 companies).

Change 2021 → 2024: Total assets -15 %

Accounts of the company itself (not consolidated).

The full file covers 9 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Apotheek Bellens's annual accounts

20242023202220212020
Net result−2,680 €
Equity17,176 €
Cash11,010 €
EBITDA58,889 €
Total assets195,155 €

Filed annual accounts

  • Year ended 31 Dec 2024filed on 02 Sep 2025
  • Year ended 31 Dec 2023filed on 24 Jun 2025
  • Year ended 31 Dec 2022filed on 27 Feb 2024
  • Year ended 31 Dec 2021filed on 23 Jan 2024
  • Year ended 31 Dec 2020filed on 10 Jul 2022

Apotheek Bellens's financial analysis

Management and control of Apotheek Bellens

1 active director(s) in the register.

Apotheek Bellens's shareholders and holdings →

Apotheek Bellens's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0426.644.008
VAT number
BE0426644008
Peppol
Registered · 0208:0426644008 · as of 10 Nov 2026
Legal form
SRL
Incorporated
29 Dec 1984
Registered office
9160 Lokeren
Latest accounts
2024 · filed on 02 Sep 2025
Activity
Retail sale of pharmaceutical products (NACE 47730)

Apotheek Bellens (SRL) has been based in Lokeren since 1984, active in: retail sale of pharmaceutical products. For 2024, it reports a net loss of 2,680 € and equity of 17,176 €; its revenue is not published. Its solvency stands at 8.8%, below the median of its sector (44.2%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Apotheek Bellens

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Apotheek Bellens

What is the revenue of Apotheek Bellens?

Apotheek Bellens files its accounts in a format where revenue is optional: it is not published for 2024.

What is the VAT number of Apotheek Bellens?

In Belgium, the VAT number is the company number prefixed with BE: BE0426644008 for Apotheek Bellens, if the company is VAT-registered. Its company number (CBE) is 0426.644.008.

Where is the registered office of Apotheek Bellens?

According to the CBE register, the registered office of Apotheek Bellens is in 9160 Lokeren.

What is the equity of Apotheek Bellens?

At the close of the 2024 financial year, the equity of Apotheek Bellens amounts to 17,176 €, a solvency of 8.8% of total assets.

Who manages Apotheek Bellens?

The register lists 1 active mandates at Apotheek Bellens. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Apotheek Bellens

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 07 Jul 2026

No credit card, no commitment.

What each plan unlocks →